| Term 
 
        | How does NO act to relax smooth muscle? |  | Definition 
 
        | activates guanylate cyclase, which produces cGMP (which is broken down by PDE). cGMP activates protein kinase that prevents release of Ca from ER, leading to muscle relaxation. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nitroglycerin mode of action, effect/use |  | Definition 
 
        | NO donor, for acute angina, also reduces bp (dose dependent), requires sulfhydryl-containing cysteine -> depletion of cysteine = nitrate tolerance. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Treatment of angina and cyanide poisoning (by creating methemoglobin which sequesters cyanide as non-toxic cyanomethemoglobin. Methemoglobin converted back to hemoglobin by methylene blue). Also illegal inhalant that produces euphoria (poppers). |  | 
        |  | 
        
        | Term 
 
        | isosorbide mononitrate and dinitrate |  | Definition 
 
        | NO donor with longer t1/2's (5 hrs/1 hr) than nitroglycerin (minutes, need expensive patches) |  | 
        |  | 
        
        | Term 
 
        | nicorandil, effect, arrhythmias? side effects? |  | Definition 
 
        | NO donor (increases cGMP) and K-channel opener (hyperpolarizes cell), arterial and venous relaxation/dilation; doesn't cause arrhythmias because is selective of vascular potassium channels (no opening of cardiac or pancreatic channels); mouth ulcers |  | 
        |  | 
        
        | Term 
 
        | Ranolazine mode of action, effect |  | Definition 
 
        | indirectly reduces available Ca in cardiac muscle by altering the transcellular late Na current which affects sodium dependent calcium channels, relaxes heart muscle and reduces cardiac ischemia (lack of O2) |  | 
        |  | 
        
        | Term 
 
        | Trimetazidine mode of action, effect |  | Definition 
 
        | shifts cardiac metabolism from fatty acid beta oxidation toward glucose oxidation reducing O2 consuption, relaxes cardiac muscle/cardioprotective |  | 
        |  | 
        
        | Term 
 
        | Ivabradine mode of action, effect |  | Definition 
 
        | Inhibits sinus node pacemaking current (enhanced PNS effect), slows heart rate without side effects of beta-1 blockers (reduced contractility) and beta-2 blockage (prevention of bronchodilation) |  | 
        |  | 
        
        | Term 
 
        | DON'T use NO donors with these drugs |  | Definition 
 
        | PDE 5 inhibitors like sildenafil (also relax smooth muscle, take off nitrates for the day), alpha-1 blockers (block constriction of blood vessels and reduce bp like NO donors) |  | 
        |  |